Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

amneal pharmaceuticals llc - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). - patients with hypercalcemia. patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. calcium acetate capsules contain calcium acetate and is excreted in human milk. human milk feeding by a mother receiving calcium acetate is not expected to harm an infant, provided maternal serum calcium levels are appropriately monitored. safety and effectiveness in pediatric patients have not been established. clinical studies of calcium acetate did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other clinical experience has not identified differences in responses between elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

american regent, inc. - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - calcium chloride 100 mg in 1 ml - calcium chloride is indicated in the immediate treatment of hypocalcemic tetany.  other therapy, such as parathyroid hormone or vitamin d, may be indicated according to the etiology of the tetany. it is also important to institute oral calcium therapy as soon as practicable. calcium salts have been used as adjunctive therapy in a number of conditions, including the following: - insect bites or stings, such as black widow spider bites. sensitivity reactions, particularly when characterized by urticaria. as an aid in the treatment of depression due to overdosage of magnesium sulfate. as an aid in the management of the acute symptoms in lead colic. in cardiac resuscitation, particularly after open heart surgery, calcium chloride has been used when epinephrine has failed to improve weak or ineffective myocardial contractions. insect bites or stings, such as black widow spider bites. sensitivity reactions, particularly when characterized by urticaria. as an aid in the treatment of depression due to overdo

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

hospira, inc. - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - calcium chloride 100 mg in 1 ml - calcium chloride injection is indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia. limitations of use the safety and effectiveness of calcium chloride injection for long-term use has not been established. calcium chloride injection is contraindicated in: newborns (up to 28 days of age) if they require (or are expected to require) ceftriaxone intravenous treatment because of the risk of precipitation of ceftriaxone-calcium, regardless of whether these products would be received at different times or through separate intravenous lines [see warnings and precautions (5.1)] .       risk summary administration of calcium chloride injection for the treatment of acute symptomatic hypocalcemia during pregnancy is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. there are risks to the mother and the fetus associated with development of hypocalcemia during pregnancy (see clinical considerations) . animal reproduction studies have n

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

nutrivital pty ltd - calcium ascorbate dihydrate, quantity: 1000 mg/g (equivalent: ascorbic acid, qty 820.76 mg/g; equivalent: calcium, qty 93.8 mg/g) - powder, oral - excipient ingredients: - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support healthy teeth ; aid/assist/helps connective tissue production/formation ; maintain/support bone health ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system function ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; maintain/support skin health ; maintain/support wound healing

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - calcium ascorbate dihydrate, quantity: 121 mg (equivalent: ascorbic acid, qty 100 mg); folic acid, quantity: 500 microgram; garlic oil, quantity: 333 microgram; selenomethionine, quantity: 64.5 microgram (equivalent: selenium, qty 26 microgram); zinc sulfate monohydrate, quantity: 69.2 mg (equivalent: zinc, qty 25 mg); d-alpha-tocopherol, quantity: 400 iu; lycopene, quantity: 6 mg - capsule, soft - excipient ingredients: purified water; hydrogenated vegetable oil; soya oil; carrageenan; hydroxypropyl starch; calcium hydrogen phosphate dihydrate; yellow beeswax; iron oxide black; iron oxide red; dibasic sodium phosphate; lecithin; glycerol; maize oil; dl-alpha-tocopherol - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; helps enhance/promote preconception health ; maintain/support preconception health ; maintain/support reproductive system health ; helps maintain/support testosterone formation/synthesis ; maintain/support semen health ; maintain/support sperm health ; maintain/support sperm motility ; maintain/support sperm production ; maintain/support testosterone level

Israel - Tiếng Anh - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - tablets effervescent - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - calcium ascorbate dihydrate, quantity: 27.23 mg (equivalent: ascorbic acid, qty 22.5 mg; equivalent: calcium, qty 2.55 mg); vitis vinifera, quantity: 118.75 mg (equivalent: vitis vinifera, qty 14.25 g; equivalent: procyanidins (of vitis vinifera), qty 95 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; hypromellose; microcrystalline cellulose; povidone; crospovidone; colloidal anhydrous silica; carnauba wax; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support collagen health ; maintain/support general health and wellbeing ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; decrease/reduce/relieve symptoms of mild varicose veins ; decrease/reduce/relieve aching/tired legs/leg heaviness associated with mild varicose veins ; decrease/reduce/relieve itchy legs associated with mild varicose veins ; decrease/reduce/relieve pain associated with mild varicose veins ; decrease/reduce/relieve leg swelling associated mild varicose veins ; maintain/support skin health ; maintain/support wound healing

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

rf six pty ltd - calcium ascorbate dihydrate, quantity: 60.382 mg (equivalent: ascorbic acid, qty 50 mg); vaccinium macrocarpon, quantity: 160 mg (equivalent: vaccinium macrocarpon, qty 4 g); vaccinium macrocarpon, quantity: 35 mg (equivalent: vaccinium macrocarpon, qty 21 g) - capsule, hard - excipient ingredients: purified water; magnesium stearate; gelatin; calcium phosphate; magnesium citrate; sodium lauryl sulfate; silicon dioxide; maltodextrin - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support urinary tract health